Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.5 USD | +0.81% | -3.05% | +15.15% |
31/05 | Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival | RE |
31/05 | Sector Update: Health Care | MT |
Sales 2024 * | 64.12B 5,348B | Sales 2025 * | 68.54B 5,717B | Capitalization | 318B 26,522B |
---|---|---|---|---|---|
Net income 2024 * | 19.51B 1,627B | Net income 2025 * | 22.25B 1,856B | EV / Sales 2024 * | 5.25 x |
Net Debt 2024 * | 18.6B 1,551B | Net Debt 2025 * | 7.29B 608B | EV / Sales 2025 * | 4.75 x |
P/E ratio 2024 * |
16.2
x | P/E ratio 2025 * |
14.1
x | Employees | 71,000 |
Yield 2024 * |
2.46% | Yield 2025 * |
2.61% | Free-Float | 70.77% |
Latest transcript on Merck & Co., Inc.
1 day | +0.81% | ||
1 week | -3.05% | ||
1 month | -2.85% | ||
3 months | -1.27% | ||
6 months | +22.50% | ||
Current year | +15.15% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Davis
CEO | Chief Executive Officer | 57 | 01/14/01 |
Director of Finance/CFO | 55 | 01/90/01 | |
Dave Williams
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tom Glocer
BRD | Director/Board Member | 63 | 27/07/27 |
Pamela Craig
BRD | Director/Board Member | 67 | 01/15/01 |
Inge Thulin
BRD | Director/Board Member | 69 | 01/18/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.34% | 254 M€ | +13.69% | - | |
5.61% | 17 M€ | +6.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 125.5 | +0.81% | 18,150,452 |
30/24/30 | 124.5 | -1.09% | 13,003,476 |
29/24/29 | 125.9 | -0.15% | 8,527,837 |
28/24/28 | 126.1 | -2.63% | 10,263,383 |
24/24/24 | 129.5 | -1.22% | 5,983,846 |
Delayed Quote Nyse, May 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.15% | 318B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- MRK Stock